Group One Trading’s Pacira BioSciences PCRX Stock Holding History

Group One Trading’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,500	Closed	-$116K	–	8459
2025 Q4	$116K	Buy	4,500 +1,600	+55%	+$38K	﹤0.01%	4871
2025 Q3	$74.7K	Sell	2,900 -300	-9%	-$7.37K	﹤0.01%	5596
2025 Q2	$76.5K	Sell	3,200 -1,700	-35%	-$42.9K	﹤0.01%	5209
2025 Q1	$122K	Sell	4,900 -1,900	-28%	-$45.5K	﹤0.01%	4441
2024 Q4	$128K	Buy	6,800 +2,900	+74%	+$50.9K	﹤0.01%	4307
2024 Q3	$58.7K	Buy	3,900 +2,700	+225%	+$46.2K	﹤0.01%	4544
2024 Q2	$34.3K	Buy	+1,200	New	+$34.2K	﹤0.01%	4803
2024 Q1	–	Sell	-7,700	Closed	-$260K	–	7746
2023 Q4	$260K	Buy	7,700 +6,700	+670%	+$196K	﹤0.01%	3625
2023 Q3	$30.7K	Hold	1,000	–	–	﹤0.01%	5525
2023 Q2	$40.1K	Buy	+1,000	New	+$41.3K	﹤0.01%	5449
2023 Q1	–	Sell	-200	Closed	-$7.72K	–	7755
2022 Q4	$7.72K	Sell	200 -6,000	-97%	-$292K	﹤0.01%	6140
2022 Q3	$330K	Buy	6,200 +2,900	+88%	+$161K	﹤0.01%	3644
2022 Q2	$192K	Buy	3,300 +3,000	+1,000%	+$197K	﹤0.01%	4353
2022 Q1	$23K	Sell	300 -100	-25%	-$6.67K	﹤0.01%	6667
2021 Q4	$24K	Sell	400 -300	-43%	-$16.5K	﹤0.01%	6870
2021 Q3	$39K	Sell	700 -600	-46%	-$34.6K	﹤0.01%	6736
2021 Q2	$79K	Hold	1,300	–	–	﹤0.01%	6185
2021 Q1	$91K	Sell	1,300 -4,500	-78%	-$321K	﹤0.01%	5745
2020 Q4	$347K	Buy	+5,800	New	+$340K	﹤0.01%	3599
2020 Q3	–	Sell	-900	Closed	-$47K	–	6433
2020 Q2	$47K	Sell	900 -63,700	-99%	-$2.66M	﹤0.01%	4408
2020 Q1	$2.17M	Buy	64,600 +62,800	+3,489%	+$2.61M	0.02%	987
2019 Q4	$82K	Buy	1,800 +900	+100%	+$38.2K	﹤0.01%	3762
2019 Q3	$34K	Sell	900 -1,600	-64%	-$63.9K	﹤0.01%	4162
2019 Q2	$109K	Sell	2,500 -16,100	-87%	-$684K	﹤0.01%	3289
2019 Q1	$708K	Sell	18,600 -37,700	-67%	-$1.47M	0.01%	1675
2018 Q4	$2.42M	Sell	56,300 -26,400	-32%	-$1.23M	0.02%	904
2018 Q3	$4.07M	Buy	82,700 +69,900	+546%	+$3.02M	0.03%	694
2018 Q2	$410K	Sell	12,800 -6,000	-32%	-$207K	﹤0.01%	2459
2018 Q1	$586K	Sell	18,800 -26,400	-58%	-$940K	0.01%	1931
2017 Q4	$2.06M	Buy	45,200 +28,000	+163%	+$1.11M	0.01%	1170
2017 Q3	$646K	Sell	17,200 -12,100	-41%	-$487K	0.01%	1872
2017 Q2	$1.4M	Sell	29,300 -24,200	-45%	-$1.12M	0.01%	1201
2017 Q1	$2.44M	Buy	53,500 +36,200	+209%	+$1.56M	0.03%	743
2016 Q4	$559K	Sell	17,300 -1,200	-6%	-$40K	0.01%	1690
2016 Q3	$633K	Sell	18,500 -500	-3%	-$19.6K	0.01%	1638
2016 Q2	$641K	Buy	19,000 +2,300	+14%	+$113K	0.01%	1562
2016 Q1	$885K	Buy	16,700 +1,300	+8%	+$76K	0.01%	1264
2015 Q4	$1.18M	Buy	15,400 +4,600	+43%	+$260K	0.01%	1204
2015 Q3	$444K	Sell	10,800 -23,400	-68%	-$1.43M	0.01%	1867
2015 Q2	$2.42M	Buy	34,200 +13,600	+66%	+$1.07M	0.03%	639
2015 Q1	$1.83M	Sell	20,600 -4,900	-19%	-$497K	0.03%	682
2014 Q4	$2.26M	Sell	25,500 -15,100	-37%	-$1.43M	0.03%	588
2014 Q3	$3.94M	Buy	40,600 +24,700	+155%	+$2.4M	0.06%	382
2014 Q2	$1.46M	Sell	15,900 -3,500	-18%	-$267K	0.02%	895
2014 Q1	$1.36M	Sell	19,400 -22,900	-54%	-$1.56M	0.02%	864
2013 Q4	$2.43M	Buy	42,300 +32,800	+345%	+$1.72M	0.04%	544
2013 Q3	$457K	Sell	9,500 -2,100	-18%	-$76.5K	0.01%	1688
2013 Q2	$336K	Buy	+11,600	New	+$336K	0.01%	1686

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's PCRX Position: Q3 2025 in Review

Group One Trading sold out of Pacira BioSciences (PCRX) in Q3 2025, closing a stake of 357 shares — an estimated $8.77K sold.

Group One Trading first reported a position in PCRX in Q2 2013 and held it in 28 quarters. The position peaked at $1.39M in Q1 2015. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

Group One Trading reported no remaining Pacira BioSciences position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 357 Pacira BioSciences shares in Q3 2025, an estimated $8.77K.
Group One Trading first reported a position in Pacira BioSciences in Q2 2013 and held it in 28 quarters.
Group One Trading's Pacira BioSciences position peaked at $1.39M in Q1 2015.
239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.